French Pharmaceuticals & Biotech Potentially Undervalued Companies

Sanofi

Market Cap: €112.8b

A healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally.

Vetoquinol

Market Cap: €865.8m

A veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region.

Oncodesign Société Anonyme

Market Cap: €99.4m

Oncodesign Société Anonyme, a biopharmaceutical company, conducts research and development work on new therapeutic and diagnostic tools with pharmaceutical firms, biotech companies, public research institutions, and investment groups.

Cellectis

Market Cap: €98.2m

A clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates.

Eurofins Scientific

Market Cap: €10.2b

Provides various analytical testing and laboratory services worldwide.

Virbac

Market Cap: €2.7b

Manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, and the Pacific.

Valneva

Market Cap: €474.4m

A specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs.

Valbiotis

Market Cap: €17.9m

Engages in the research and development of dietary supplements to prevent metabolic and cardiovascular diseases in France.

Ipsen

Market Cap: €8.5b

Operates as a biopharmaceutical company worldwide.

Plant Advanced Technologies

Market Cap: €11.9m

A plant biotechnology company, produces and sells actives for cosmetic, pharmaceutical, and agrochemical markets in France.

OSE Immunotherapeutics

Market Cap: €132.7m

A clinical-stage biotechnology company, develops immunotherapies in the areas of immune-oncology and immune-inflammation in France and internationally.

PHAXIAM Therapeutics

Market Cap: €2.0m

A biopharmaceutical company, focuses on developing treatments for resistant bacterial infections in France and the United States.

Oncodesign Precision Medicine Société anonyme

Market Cap: €6.1m

A biopharmaceutical company, engages in the precision medicine business.

Aelis Farma

Market Cap: €16.5m

A clinical-stage biopharmaceutical company, focuses on discovering and developing drug candidates for the treatment of central nervous system disorders in France.

Theranexus Société Anonyme

Market Cap: €8.7m

A biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system disorders.

MedinCell

Market Cap: €543.2m

A pharmaceutical company, develops long acting injectables in various therapeutic areas in France.

Euroapi

Market Cap: €300.9m

Develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use.

Genfit

Market Cap: €191.1m

A late-stage biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases.

MaaT Pharma

Market Cap: €78.2m

A late-stage clinical company, engages in the development of gut microbiome-driven therapies to modulate the immune system and improve cancer survival.